NDC 49281-190
IMOGAM RABIES-HT
Human Rabies Virus Immune Globulin
IMOGAM RABIES-HT is a Intramuscular Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Human Rabies Virus Immune Globulin.
| Product ID | 49281-190_53595fe1-05a5-4db7-8f62-4535188ab5ac |
| NDC | 49281-190 |
| Product Type | Plasma Derivative |
| Proprietary Name | IMOGAM RABIES-HT |
| Generic Name | Human Rabies Virus Immune Globulin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 1984-04-27 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103932 |
| Labeler Name | Sanofi Pasteur Inc. |
| Substance Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Active Ingredient Strength | 150 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |